ketoconazole has been researched along with Chlamydia Infections in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Chlamydia Infections: Infections with bacteria of the genus CHLAMYDIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Good, JA | 1 |
| Silver, J | 1 |
| Núñez-Otero, C | 1 |
| Bahnan, W | 1 |
| Krishnan, KS | 1 |
| Salin, O | 1 |
| Engström, P | 1 |
| Svensson, R | 1 |
| Artursson, P | 1 |
| Gylfe, Å | 1 |
| Bergström, S | 1 |
| Almqvist, F | 1 |
1 other study available for ketoconazole and Chlamydia Infections
| Article | Year |
|---|---|
Thiazolino 2-Pyridone Amide Inhibitors of Chlamydia trachomatis Infectivity.
Topics: Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Dose-Response Relationship, Drug | 2016 |